The Committee will hear from:
- Sean Dennehey, Acting Chief Executive, Intellectual Property Office.
- Alex Denoon, Partner, Lawford Davies Denoon.
- Professor Peter Andrews, Arthur Jackson Professor of Biomedical Science, University of Sheffield.
In the course of their inquiry into regenerative medicine the Committee has heard conflicting evidence on the importance of intellectual property protection to the commercialisation of regenerative medicine treatments. Some witnesses have suggested that suitable patent protection will be vital whilst others argued that the complexity of developing treatments would provide sufficient protection to ensure investment.
This session will seek to explore both legitimate and perception-based concerns regarding intellectual property particularly in the light of coverage of the European Court of Justice ruling on the Brüstle vs Greenpeace case on the patentability of human embryonic stem cells.
The evidence session will take place at 10:40am tomorrow (Tuesday 27 November) in Committee Room 4 of the House of Lords.
Notes
1. The evidence session is open to the public. If you wish to attend you should go to Parliament's Cromwell Green Entrance and allow time for security screening.
2. You can watch the session live on the internet at www.parliamentlive.tv
3. On Tuesday 30 October some of questions asked by the Committee were suggested by users of the social media site Twitter. Details of that evidence session can be found on the Committee's website
*******
House of Lords Press Office
House of Lords
London SW1A 0PW
020 7219 8550
www.parliament.uk/lords